دورية أكاديمية
Advanced practice nurse pharmacogenomics capacity and utilization.
| العنوان: | Advanced practice nurse pharmacogenomics capacity and utilization. |
|---|---|
| المؤلفون: | Fulton CR; Health Informatics, Luddy School of Informatics, Computing, and Engineering, Indiana University-Indianapolis, Indianapolis, IN., Macagno ALM; Biostatistics Consulting Center, Department of Epidemiology and Biostatistics, School of Public Health, Indiana University Bloomington, Bloomington, Indiana., Dickinson SL; Biostatistics Consulting Center, Department of Epidemiology and Biostatistics, School of Public Health, Indiana University Bloomington, Bloomington, Indiana., Calzone K; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. |
| المصدر: | Journal of the American Association of Nurse Practitioners [J Am Assoc Nurse Pract] 2024 Jul 01; Vol. 36 (7), pp. 361-369. Date of Electronic Publication: 2024 Jul 01. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 101600770 Publication Model: Electronic Cited Medium: Internet ISSN: 2327-6924 (Electronic) Linking ISSN: 23276886 NLM ISO Abbreviation: J Am Assoc Nurse Pract Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2018- : Netherlands : Wolters Kluwer Original Publication: Malden : Wiley |
| مواضيع طبية MeSH: | Advanced Practice Nursing*/methods , Advanced Practice Nursing*/statistics & numerical data , Advanced Practice Nursing*/standards , Pharmacogenetics*/methods , Pharmacogenetics*/statistics & numerical data , Pharmacogenetics*/education, Humans ; Female ; Adult ; Male ; Surveys and Questionnaires ; Middle Aged ; Curriculum/trends ; Curriculum/standards ; Nurse Practitioners/education ; Nurse Practitioners/statistics & numerical data ; Clinical Competence/statistics & numerical data ; Clinical Competence/standards |
| مستخلص: | Background: Guided by Clinical Pharmacogenomic Implementation Consortium (CPIC) guidelines for >140 medications, pharmacogenomic tests inform medication selection and dosing to optimize efficacy while minimizing toxicities. Purpose: This study assessed pharmacogenomic self-reported curricular content, knowledge, skills, attitudes, and usage in advanced practice registered nurses (APRNs) with prescriptive privileges. Methodology: An online survey was administered assessing pharmacogenomic curricular content, knowledge, skills, attitudes, and usage. Results: Data from 266 APRNs were analyzed. Most graduated with their highest nursing degree ∼10 years ago and reported pharmacogenomic curricular content ( n = 124, 48%). Pharmacogenomic curricular content was associated with pharmacogenomic familiarity ( p = .045) but not with knowledge confidence ( p = .615). Pharmacogenomic usage, defined as ordering a pharmacogenomic test within the past year, was low ( n = 76, 29%) and most ( n = 210, 84%) reported never using CPIC Guidelines. Advanced practice registered nurses ( n = 162) who did not anticipate ordering a pharmacogenomic test in the next year ( n = 77, 48%) indicated that they did not know what test to order. Conclusions: Deficits were identified in APRN pharmacogenomic knowledge and skills despite academic training. Most reported not ordering pharmacogenomic tests, did not know what test to order, and did not use CPIC guidelines. Implications: Pharmacogenomics is a quality and safety issue. Academic training did not result in practice integration and most reported capacity deficits. Recommendation for overcoming academic deficits include: (1) assessment of pharmacogenomics curricular content and faculty teaching capacity; (2) training addressing identified deficiencies; and (3) Commission of Collegiate Nursing Education policies that include pharmacogenomics in advanced pharmacology. Practicing APRN plans include on-the-job training and/or mandatory training at the time of relicensure. Competing Interests: Competing interests: The authors report no conflicts of interest. (Copyright © 2024 American Association of Nurse Practitioners.) |
| References: | Pharmacogenomics. 2022 Jan;23(2):135-154. (PMID: 34911350) J Hum Genet. 2020 May;65(5):437-444. (PMID: 31983733) Pharmacogenomics. 2021 Jul;22(11):681-691. (PMID: 34137665) Oncol Nurs Forum. 2018 Sep 1;45(5):575-580. (PMID: 30118446) JAMA. 2021 Oct 05;326(13):1299-1309. (PMID: 34609453) J Med Educ Curric Dev. 2020 Jul 27;7:2382120520930772. (PMID: 32782929) J Am Assoc Nurse Pract. 2020 Feb 4;33(3):205-210. (PMID: 32039960) Pharmacogenomics. 2021 Jan;22(1):13-25. (PMID: 33356552) Genet Med. 2021 Sep;23(9):1589-1603. (PMID: 33927377) J Am Assoc Nurse Pract. 2019 Aug;31(8):443-446. (PMID: 31348145) Pharmacogenomics. 2019 Jun;20(9):643-657. (PMID: 31250730) JAMA Netw Open. 2021 Dec 1;4(12):e2137288. (PMID: 34870678) Annu Rev Nurs Res. 2011;29:173-90. (PMID: 22891504) Clin Genet. 2012 Oct;82(4):388-94. (PMID: 22698141) Nurse Educ Pract. 2023 Aug;71:103697. (PMID: 37437513) Nurs Outlook. 2018 May - Jun;66(3):244-253. (PMID: 29544651) Pharmgenomics Pers Med. 2014 Jul 10;7:145-62. (PMID: 25045280) Pharmacogenomics. 2020 Oct;21(15):1085-1094. (PMID: 32969759) Pharmacogenomics. 2021 Apr;22(5):263-274. (PMID: 33657875) Br J Clin Pharmacol. 2015 Oct;80(4):868-77. (PMID: 25060532) Nurs Outlook. 2010 Jan-Feb;58(1):26-35. (PMID: 20113752) Mil Med. 2021 Dec 30;187(Suppl 1):9-17. (PMID: 34967405) Am J Med. 2017 Mar;130(3):365.e7-365.e12. (PMID: 27984006) |
| معلومات مُعتمدة: | Z99 CA999999 United States ImNIH Intramural NIH HHS; None None |
| تواريخ الأحداث: | Date Created: 20240410 Date Completed: 20240705 Latest Revision: 20240707 |
| رمز التحديث: | 20240707 |
| مُعرف محوري في PubMed: | PMC11226373 |
| DOI: | 10.1097/JXX.0000000000001007 |
| PMID: | 38595133 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2327-6924 |
|---|---|
| DOI: | 10.1097/JXX.0000000000001007 |